Skip to content

Neuro-cognitive effects of tyrosine supplementation in older adults

Neuro-cognitive effects of tyrosine supplementation in older adults - Tyrosine and the aging brain

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON42026
Enrollment
28
Registered
2014-11-12
Start date
2014-11-26
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gezonde veroudering healthy aging old age

Interventions

Subjects will receive either 150 mg/kg body weight tyrosine or 50 mg/kg body weight Fantomalt diet carbohydrate powder mixed with 100 mg/kg cornstarch (placebo condition), in both cases dissolved in

Sponsors

Radboud Universiteit Nijmegen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria (zie sectie 4.2 op pagina 12 van het protocol) In order to be eligible to participate in this study, subjects must meet all of these criteria: - Age: 60-75 years old - Proficient knowledge of the Dutch language - Right-handed - Willing to perform tasks in the MRI scanner, to come to the centre on three occasions, consuming tyrosine or a placebo and willing to fast the night before the two test sessions.

Exclusion criteria

Exclusion criteria: Exclusion criteria (see section 4.3 on page 12 of the protocol) A potential subject who meets any of the following criteria will be excluded from participation in this study (for a checklist see F1 Intake Questionnaires and Checklists): - Mini Mental State Examination score 11 - Estimated IQ

Design outcomes

Primary

MeasureTime frame
We will assess the effect of the intervention on BOLD signal measured with functional magnetic resonance imaging (fMRI) and response times and accuracy on the computerized tasks during fMRI.

Secondary

MeasureTime frame
Secondarily, effects on paper and pencil neuropsychological tasks will be assessed. Also, intervention effects on subjective measurements (e.g. self-report questionnaires, visual analogue scales), on catecholamine and serotonin metabolites (MVA - metanefrine, HVA - normetinefrine, HVA - 3-MT and 5-HIAA) in urine samples, and on physiological recordings (blood pressure, heart rate) will be measured.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)